XML 19 R6.htm IDEA: XBRL DOCUMENT v3.20.2
Unaudited Condensed Consolidated Statement of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Additional Paid-in Capital
2023 Notes
Additional Paid-in Capital
2025 Notes
Accumulated Other Comprehensive Loss
Treasury Stock
Retained Earnings
Retained Earnings
Cumulative effect, period of adoption, adjustment
Balance at Dec. 31, 2018   $ 48 $ 437,250     $ (2,588) $ (233,676) $ 152,650  
Balance (in shares) at Dec. 31, 2018   31,771,000              
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Stock compensation related to restricted stock vesting and retirement savings plan contributions   $ 1 12,451            
Proceeds from the sales of stock through the Employee Stock Purchase Plan (in shares)   5,000              
Proceeds from the sales of stock through the Employee Stock Purchase Plan     130            
Stock compensation related to restricted stock vesting and retirement savings plan contributions (in shares)   439,000              
Issuance of stock in conjunction with acquisition including stock attributed to future compensation     1,456            
Equity component of convertible notes       $ 0 $ 0        
Proceeds from sale of hedges related to 2023 convertible notes       0          
Purchases of warrants related to 2023 convertible notes       0          
Debt issuance costs of 2025 convertible notes allocated to equity, net of tax     0            
Purchase of hedges on 2025 convertible notes, net of tax     0            
Proceeds from issuance of warrants on 2025 convertible notes                
Purchases of treasury stock and buyback of shares for taxes (in shares)   (819,000)              
Foreign currency translation adjustment $ (48)         (48)      
Purchases of treasury stock and buyback of shares for taxes             (23,759)    
Issuance of stock in conjunction with acquisition (in shares)   54,000              
Net income 25,333             25,333  
Balance at Sep. 30, 2019 $ 369,248 $ 49 451,287     (2,636) (257,435) 177,983  
Balance (in shares) at Sep. 30, 2019 31,450,000 31,450,000              
Balance at Jun. 30, 2019   $ 49 447,146     (2,351) (253,901) 168,204  
Balance (in shares) at Jun. 30, 2019 31,526,000                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Stock compensation related to restricted stock vesting and retirement savings plan contributions   0 4,096            
Proceeds from the sales of stock through the Employee Stock Purchase Plan (in shares) 1,000                
Proceeds from the sales of stock through the Employee Stock Purchase Plan     45            
Stock compensation related to restricted stock vesting and retirement savings plan contributions (in shares) 25,000                
Issuance of stock in conjunction with acquisition including stock attributed to future compensation     0            
Equity component of convertible notes       0 0        
Proceeds from sale of hedges related to 2023 convertible notes       0          
Purchases of warrants related to 2023 convertible notes       0          
Debt issuance costs of 2025 convertible notes allocated to equity, net of tax     0            
Purchase of hedges on 2025 convertible notes, net of tax     0            
Proceeds from issuance of warrants on 2025 convertible notes     0            
Purchases of treasury stock and buyback of shares for taxes (in shares) (102,000)                
Foreign currency translation adjustment $ (285)         (285)      
Purchases of treasury stock and buyback of shares for taxes             (3,534)    
Issuance of stock in conjunction with acquisition (in shares) 0                
Net income $ 9,779             9,779  
Balance at Sep. 30, 2019 $ 369,248 $ 49 451,287     (2,636) (257,435) 177,983  
Balance (in shares) at Sep. 30, 2019 31,450,000 31,450,000              
Balance at Dec. 31, 2019 $ 381,015 $ 49 455,465     (2,650) (261,624) 189,775 $ (315)
Balance (in shares) at Dec. 31, 2019 31,686,991 31,687,000              
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Stock compensation related to restricted stock vesting and retirement savings plan contributions   $ 1 13,824            
Proceeds from the sales of stock through the Employee Stock Purchase Plan (in shares)   7,000              
Proceeds from the sales of stock through the Employee Stock Purchase Plan     210            
Stock compensation related to restricted stock vesting and retirement savings plan contributions (in shares)   380,000              
Issuance of stock in conjunction with acquisition including stock attributed to future compensation     10,184            
Equity component of convertible notes       (49,856) 36,386        
Proceeds from sale of hedges related to 2023 convertible notes       47,338          
Purchases of warrants related to 2023 convertible notes       (40,699)          
Debt issuance costs of 2025 convertible notes allocated to equity, net of tax     (1,155)            
Purchase of hedges on 2025 convertible notes, net of tax     (36,387)            
Proceeds from issuance of warrants on 2025 convertible notes     22,218            
Purchases of treasury stock and buyback of shares for taxes (in shares)   (369,000)              
Foreign currency translation adjustment $ (2,126)         (2,126)      
Purchases of treasury stock and buyback of shares for taxes             (15,973)    
Issuance of stock in conjunction with acquisition (in shares)   337,000              
Net income 21,760             21,760  
Balance at Sep. 30, 2020 $ 386,425 $ 50 457,528     (4,776) (277,597) 211,220 0
Balance (in shares) at Sep. 30, 2020 32,041,550 32,042,000              
Balance at Jun. 30, 2020   $ 50 475,147     (3,702) (266,485) 205,043  
Balance (in shares) at Jun. 30, 2020 32,272,000                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Stock compensation related to restricted stock vesting and retirement savings plan contributions   0 4,419            
Proceeds from the sales of stock through the Employee Stock Purchase Plan (in shares) 3,000                
Proceeds from the sales of stock through the Employee Stock Purchase Plan     94            
Stock compensation related to restricted stock vesting and retirement savings plan contributions (in shares) 22,000                
Issuance of stock in conjunction with acquisition including stock attributed to future compensation     23            
Equity component of convertible notes       (49,856) $ 36,386        
Proceeds from sale of hedges related to 2023 convertible notes       47,338          
Purchases of warrants related to 2023 convertible notes       $ (40,699)          
Debt issuance costs of 2025 convertible notes allocated to equity, net of tax     (1,155)            
Purchase of hedges on 2025 convertible notes, net of tax     (36,387)            
Proceeds from issuance of warrants on 2025 convertible notes     22,218            
Purchases of treasury stock and buyback of shares for taxes (in shares) (255,000)                
Foreign currency translation adjustment $ (1,074)         (1,074)      
Purchases of treasury stock and buyback of shares for taxes             (11,112)    
Issuance of stock in conjunction with acquisition (in shares) 0                
Net income $ 6,177             6,177  
Balance at Sep. 30, 2020 $ 386,425 $ 50 $ 457,528     $ (4,776) $ (277,597) $ 211,220 $ 0
Balance (in shares) at Sep. 30, 2020 32,041,550 32,042,000